238.10
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt HUM?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$239.62
Offen:
$239.01
24-Stunden-Volumen:
539.32K
Relative Volume:
0.31
Marktkapitalisierung:
$28.00B
Einnahmen:
$117.76B
Nettoeinkommen (Verlust:
$1.21B
KGV:
23.93
EPS:
9.95
Netto-Cashflow:
$2.39B
1W Leistung:
+1.23%
1M Leistung:
+5.94%
6M Leistung:
-6.82%
1J Leistung:
-32.97%
Humana Inc Stock (HUM) Company Profile
Firmenname
Humana Inc
Sektor
Branche
Telefon
(502) 580-1000
Adresse
500 W MAIN ST, LOUISVILLE, KY
Vergleichen Sie HUM mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
HUM
Humana Inc
|
238.30 | 28.00B | 117.76B | 1.21B | 2.39B | 9.95 |
![]()
UNH
Unitedhealth Group Inc
|
299.17 | 275.58B | 410.06B | 22.11B | 24.86B | 23.88 |
![]()
ELV
Elevance Health Inc
|
371.30 | 86.74B | 183.12B | 5.92B | 3.67B | 25.63 |
![]()
CI
Cigna Group
|
315.01 | 82.87B | 254.47B | 5.03B | 6.01B | 18.06 |
![]()
CVS
Cvs Health Corp
|
66.17 | 81.29B | 378.96B | 5.28B | 5.94B | 4.19 |
Humana Inc Stock (HUM) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-05-01 | Hochstufung | Raymond James | Mkt Perform → Outperform |
2024-11-06 | Hochstufung | BofA Securities | Underperform → Neutral |
2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
2024-10-08 | Hochstufung | Bernstein | Mkt Perform → Outperform |
2024-10-07 | Herabstufung | Jefferies | Buy → Hold |
2024-10-07 | Herabstufung | TD Cowen | Buy → Hold |
2024-10-03 | Herabstufung | Piper Sandler | Overweight → Neutral |
2024-10-02 | Herabstufung | BofA Securities | Neutral → Underperform |
2024-10-02 | Herabstufung | Leerink Partners | Outperform → Market Perform |
2024-10-02 | Herabstufung | Stephens | Overweight → Equal-Weight |
2024-06-26 | Eingeleitet | Piper Sandler | Overweight |
2024-06-24 | Eingeleitet | Morgan Stanley | Equal-Weight |
2024-04-02 | Herabstufung | BofA Securities | Buy → Neutral |
2024-03-22 | Eingeleitet | Raymond James | Mkt Perform |
2024-03-13 | Herabstufung | Argus | Buy → Hold |
2024-03-06 | Eingeleitet | Barclays | Equal Weight |
2024-01-26 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
2024-01-25 | Herabstufung | Deutsche Bank | Buy → Hold |
2023-12-12 | Hochstufung | Argus | Hold → Buy |
2023-11-08 | Herabstufung | BofA Securities | Neutral → Underperform |
2023-07-07 | Herabstufung | JP Morgan | Overweight → Neutral |
2023-06-23 | Herabstufung | Argus | Buy → Hold |
2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
2022-12-13 | Hochstufung | Goldman | Neutral → Buy |
2022-10-26 | Hochstufung | Deutsche Bank | Hold → Buy |
2022-09-20 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
2022-06-17 | Eingeleitet | Loop Capital | Buy |
2022-05-27 | Eingeleitet | Bernstein | Mkt Perform |
2022-04-13 | Hochstufung | UBS | Neutral → Buy |
2022-01-06 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
2021-12-16 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
2021-12-14 | Eingeleitet | Goldman | Neutral |
2021-11-04 | Bestätigt | Barclays | Overweight |
2021-11-04 | Bestätigt | Credit Suisse | Outperform |
2021-11-04 | Bestätigt | Morgan Stanley | Overweight |
2021-11-04 | Bestätigt | Oppenheimer | Outperform |
2021-11-04 | Bestätigt | RBC Capital Mkts | Outperform |
2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
2021-09-10 | Eingeleitet | Cowen | Outperform |
2021-09-09 | Fortgesetzt | Barclays | Overweight |
2021-07-09 | Eingeleitet | Seaport Global Securities | Neutral |
2021-05-19 | Eingeleitet | Wells Fargo | Equal Weight |
2021-01-04 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
2020-10-02 | Eingeleitet | Bernstein | Mkt Perform |
2020-07-01 | Eingeleitet | SVB Leerink | Outperform |
2020-06-16 | Herabstufung | Cowen | Outperform → Market Perform |
2020-06-05 | Eingeleitet | Goldman | Buy |
2020-01-03 | Bestätigt | JP Morgan | Overweight |
2019-10-18 | Eingeleitet | Mizuho | Buy |
2019-09-30 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
2019-08-12 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
2019-04-23 | Eingeleitet | UBS | Neutral |
2019-01-14 | Eingeleitet | Stephens | Overweight |
2018-12-20 | Hochstufung | JP Morgan | Neutral → Overweight |
2018-11-08 | Bestätigt | BofA/Merrill | Buy |
2018-09-13 | Eingeleitet | Barclays | Overweight |
2018-07-12 | Fortgesetzt | Morgan Stanley | Overweight |
2018-07-06 | Bestätigt | Piper Jaffray | Overweight |
2018-06-01 | Fortgesetzt | Citigroup | Buy |
2018-02-08 | Hochstufung | Credit Suisse | Neutral → Outperform |
2018-02-08 | Bestätigt | Leerink Partners | Outperform |
2018-01-12 | Hochstufung | Jefferies | Hold → Buy |
Alle ansehen
Humana Inc Aktie (HUM) Neueste Nachrichten
Humana Launches “Invite” Campaign to Get More Seniors Pickleball-Ready - Athletech News
Humana’s SWOT analysis: stock outlook amid Medicare stars challenge By Investing.com - Investing.com India
Humana details plans to grow its primary care business as competing clinics shutter - Endpoints News
Humana stock rating reiterated at Bernstein on Medicare Advantage outlook By Investing.com - Investing.com India
Humana Launches “Invite” Campaign to Inspire Active Aging Through Pickleball and Community Connection | HUM Stock News - GuruFocus
Humana Launches “Invite” Campaign to Inspire Active Aging Through Pickleball and Community Connection - Business Wire
PKO Investment Management Joint Stock Co Decreases Holdings in Humana Inc. (NYSE:HUM) - MarketBeat
Health Insurance Co. Owes Workers OT Wages, Suit Claims - Law360
Stock Movers: Jetblue, Humana, Solar Stocks - Bloomberg
Nurse Managers Claim Humana Violated FLSA, Owes Overtime Pay - Bloomberg Law News
Bank of America Cuts Humana (NYSE:HUM) Price Target to $260.00 - MarketBeat
Humana (HUM) Target Price Lowered by B of A Securities | HUM Stock News - GuruFocus
Humana price target maintained at $268 on long-term strategy shift - Investing.com
Humana Aims For Earnings Surge With New Strategies - Finimize
Humana’s cautious defense of Medicare Advantage - Healthcare Dive
Truist Cuts Price Target on Humana to $280 From $305, Keeps Hold Rating - MarketScreener
Truist Securities Maintains Hold Rating on Humana (HUM), Lowers Price Target | HUM Stock News - GuruFocus
Humana price target maintained at $283 by RBC on long-term growth view - Investing.com
Truist Financial Issues Pessimistic Forecast for Humana (NYSE:HUM) Stock Price - MarketBeat
Humana stock outlook positive as Mizuho reiterates outperform rating - Investing.com
FNY Investment Advisers LLC Sells 26,900 Shares of Humana Inc. (NYSE:HUM) - MarketBeat
Pullen Investment Management LLC Takes Position in Humana Inc. (NYSE:HUM) - MarketBeat
Humana: Management Makes Bull Case for Long-Term Shareholders at Analyst Day - Morningstar
Humana's Management Team Outlines Ambitious Long-Term Profit Goals at Analyst Day - Morningstar
To boost Medicare Advantage profitability, Humana turns to old tactic: the annual wellness visit - STAT
Transcript : Humana Inc.Analyst/Investor Day - MarketScreener
Humana (HUM) Targets 2028 for Four-Star Medicare Rating - GuruFocus
Humana (NYSE:HUM) Downgraded to Hold Rating by Wall Street Zen - MarketBeat
Humana doesn't project achieving four-star Medicare Advantage rating until 2028 - Seeking Alpha
Humana plans for business with assumption of losing stars lawsuit By Investing.com - Investing.com Nigeria
Humana Inc. (NYSE:HUM) Shares Sold by Mn Services Vermogensbeheer B.V. - MarketBeat
Tobam Trims Stock Position in Humana Inc. (NYSE:HUM) - MarketBeat
Humana (NYSE:HUM) Given a $268.00 Price Target by Barclays Analysts - MarketBeat
Pallas Capital Advisors LLC Purchases New Shares in Humana Inc. (NYSE:HUM) - MarketBeat
Humana’s SWOT analysis: healthcare giant faces legal hurdles, cost challenges - Investing.com
Analysts Set Expectations for Humana FY2026 Earnings - MarketBeat
SG Americas Securities LLC Raises Stock Holdings in Humana Inc. (NYSE:HUM) - MarketBeat
Humana, Aetna Underpaid For 340B Drugs, New Suits Say - Law360
Mercy and Humana Team Up for the First Time to Open 65 Prime+ Clinics in Missouri - Morningstar
August 1st Options Now Available For Humana (HUM) - Nasdaq
Humana Recognizes 10 Inspiring Athletes Who Are Redefining What It Means to Age | HUM Stock News - GuruFocus
Humana (HUM): Barclays Lowers Price Target but Maintains Rating - GuruFocus
Humana Recognizes 10 Inspiring Athletes Who Are Redefining What It Means to Age - Business Wire
Healthcare Innovation: How Humana's New Tech Partnership Uncovers 10 Care Gaps Per Patient, Wins KLAS Award - Stock Titan
Barclays Adjusts Price Target on Humana to $268 From $273 - MarketScreener
Gateway Investment Advisers LLC Raises Holdings in Humana Inc. (NYSE:HUM) - MarketBeat
Humana (HUM) Price Target Reduced by Barclays Ahead of Investor Day | HUM Stock News - GuruFocus
UnitedHealth's Medical Membership Rises: Can It Maintain the Momentum? - The Globe and Mail
New PPO Dental Plans More Competitive Against HMOs - Quantisnow
Is Humana Stock Underperforming The Dow? - Barchart.com
Jefferies CUTS Humana stock price target on margin pressure - Investing.com
Finanzdaten der Humana Inc-Aktie (HUM)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):